Showing results (651-660 of 777) with videos related to

Sort By:
Pageof 78
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 7, 2024
Understanding How, Why and for Whom Link Work Interventions Promote Access in Community Healthcare Settings in the United Kingdom: A Realist ReviewRebecca Golby, Fiona Lobban, Louise Laverty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDGBrad Kline, Surekha Yadav, Youngho Seo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2006
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expressionR A Soo, J Wu, A Aggarwal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Likelihood of blood culture positivity using SeptiCyte RAPIDKrupa Navalkar, Alyse Wheelock, Melissa Gregory, et al.
Cancer Medicine|November 21, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate CancerDaniel H Kwon, Lauren Trihy, Nika Darvish, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate CancerRahul R Aggarwal, Jacqueline Vuky, David VanderWeele, et al.
Cancer Research Communications|June 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro, et al.
Pageof 78